Salesmotion
Book a demo

Alternatives

Top 5 Evaluate Alternatives for Life Sciences Teams (2026)

Evaluate (Evaluate Pharma) is the reference source for consensus drug forecasts and valuation, priced per organization with no public price. For R&D and market research the alternatives are Cortellis, Citeline, GlobalData and IQVIA; for selling into sponsors, Salesmotion starts at $85/month on a monthly contract.

Book a demoTry interactive demo
G24.8 rating on G2
Semir JahicBy Semir JahicCEO & Co-Founder, SalesmotionLast reviewed

Top picks at a glance

  1. #1

    Salesmotion

    Best for: BD, sales, and commercial teams (CROs, CDMOs, labs, vendors) that need to find sponsors to sell to and reach the right people

  2. #2

    Cortellis (formerly Clarivate)

    Best for: R&D, regulatory, and competitive-strategy teams needing curated pipeline and regulatory data

  3. #3

    Citeline

    Best for: Trial planning, competitive intelligence, and BD&L teams needing curated pipeline and trial data

At a glance

How Evaluate Alternatives Compare

Side-by-side comparison of the key capabilities that matter most.

FeatureSalesmotionCortellisCitelineGlobalDataIQVIA
Primary StrengthCommercial sponsor discovery, signals & outreachCurated R&D, deals & regulatory intelligencePipeline & clinical-trial intelligenceBroad pharma datasets with analyst validationCommercial analytics & real-world evidence
Best ForBD & sales teams selling into sponsorsR&D, regulatory & competitive intelligenceTrial planning & competitive intelligenceMarket research & strategy teamsCommercial analytics, HCP engagement & real-world evidence
Forecasting / ValuationBuilt for selling; pairs with a forecasting platformDRG Market Assessment and epidemiologyPipeline and trial data (Pharmaprojects, Trialtrove)Therapeutic analysis and price intelligenceReal-world data, launch strategy and pricing & market access
Decision-Maker ContactsVerified contacts (email + phone)Research data, delivered through APIs and data productsInvestigators and sites (Sitetrove)Named executives; verified emails and dials are not marketedOneKey reference data on HCPs and HCOs
AI OutreachAI drafts anchored to the triggerAI-assisted research and regulatory intelligenceElla AI chat assistant, built for search strategiesAI sales analyst (Sam): account plans and pitch scripts; no email sendingField Force Agent for planning HCP engagements
Pricing$85/mo for individuals. Custom pricing for teams & enterprise.Custom, enterprise-onlyCustom, enterprise-onlyCustom, demo-gatedNot published; quoted on request
Rating (G2)4.8/5————

Why teams explore Evaluate alternatives

Evaluate opened in London in 1996 and became part of Norstella in 2020. Evaluate Pharma is the reference dataset for consensus drug-sales forecasts, with 1.5m+ consensus forecasts of 10,000 products dating back to 2003 and consensus forecasts for almost 6,000 drugs. Around it sit Evaluate Omnium for risk and return modelling, Evaluate Epi, Evaluate Medtech, Biomedtracker, Datamonitor Healthcare and a CDMO Intelligence product, with Ask Ella as the AI analyst across them.

Teams look for alternatives for two reasons. Some want a different or broader angle on R&D and market intelligence, which points to Cortellis, Citeline, GlobalData or IQVIA. Others are commercial teams with a different job to do. Evaluate is built for forecasting and valuation; Salesmotion is built for the selling motion.

If your goal is to turn sponsor activity into pipeline (finding which sponsors to pursue, knowing when a buying window opens, reaching decision-makers and sending outreach) you need account intelligence built for commercial teams. This guide covers both the research alternatives and the commercial option.

What buyers tell us

We held 55 sales and customer calls between August and October 2026, 17 of them with life sciences teams. They asked for current, traceable data and fewer tools to cross-check.

“it's a whole lot of Frankensteining ... having to go to multiple sources just to confirm each step of the way”
Business development rep, CRO
“So how confident are you that your data is up to date?”
Business development rep, CRO
“without having to duplicate the task between your solution and our internal sales tool.”
Business development director, CRO

Why Trust This Guide?

Semir Jahic, CEO & Co-Founder of Salesmotion

I'm Semir Jahic, CEO of Salesmotion. Before founding an account intelligence platform, I spent years in enterprise sales at Salesforce and led revenue teams at Clari. We work with life-sciences commercial teams, including Cytel. If your job is forecasting or valuation, Evaluate is the right tool, and I'll say so plainly. The point of this guide is to help you match the tool to the job, whether that is forecasting, R&D research or commercial selling, using each vendor's own published information.

Semir Jahic — CEO & Co-Founder, Salesmotion

Detailed Breakdown

Best Evaluate Alternatives

An in-depth look at each platform, including features, pricing, and limitations.

1

Salesmotion

Our Pick
G2: 4.8/5

Salesmotion for Life Sciences is an AI-native sponsor-intelligence platform for the commercial side of life sciences. It continuously discovers and classifies sponsors from clinical trials, filings, funding, and the open web, ranks them by fit to what you sell, and surfaces real-time buying signals — then adds verified decision-maker contacts with email and phone and one-click AI outreach.

Evaluate is built for forecasting and valuation. Salesmotion is built for the job that comes after the market view: finding and winning sponsor business. The two fit together: Evaluate for where the market is going, Salesmotion for who to call this week.

Best for:BD, sales, and commercial teams (CROs, CDMOs, labs, vendors) that need to find sponsors to sell to and reach the right people

Key Features

  • Continuous AI discovery of sponsors, ranked by fit to what you sell
  • Real-time buying signals: first-in-human, phase transitions, readouts, funding
  • Verified decision-maker contacts with email and phone
  • AI-drafted outreach anchored to the real trigger
  • Native Salesforce and HubSpot sync; full API access
  • Live in days, no enterprise implementation project

Limitations

  • Evaluate is the right tool for consensus forecasts, valuation and risk and return modelling
  • Built for commercial teams; strategy and finance analysts are better served by a forecasting platform
Pricing: $85/mo for individuals — flexible monthly billing. Custom pricing for teams and enterprise on request.
G24.8 rating on G2Book a demo
2

Cortellis (formerly Clarivate)

Visit site

Cortellis is the R&D intelligence suite long sold by Clarivate. Clarivate completed the sale of its Life Sciences & Healthcare segment to Altaris on 6 October 2026, and the business now operates as an independent company. Cortellis spans competitive, deals, product, CMC, drug discovery, clinical trials and regulatory intelligence, and the same business includes DRG market assessment and epidemiology, BioWorld news and OFF-X safety intelligence. It reports 3000+ life sciences clients around the world.

For teams that want analytical depth beyond forecasting, it is a strong alternative. It is built for R&D, regulatory and market-access work rather than commercial prospecting.

Best for:R&D, regulatory, and competitive-strategy teams needing curated pipeline and regulatory data

Key Features

  • Cortellis Competitive, Deals and Product Intelligence
  • Cortellis Clinical Trials and Regulatory Intelligence
  • Cortellis CMC and Drug Discovery Intelligence
  • DRG Market Assessment and Epidemiology Intelligence
  • APIs and data products for existing portals and dashboards

Limitations

  • Pricing is quoted per organization and not published
  • Built for R&D and regulatory research rather than sales prospecting
Pricing: The former Clarivate Life Sciences & Healthcare business (Cortellis, DRG), owned by Altaris since October 2026, does not publish list pricing; contracts are quoted per organization; contracts are quoted per organization.
3

Citeline

Visit site

Citeline (Pharmaprojects, Trialtrove, Sitetrove) is pipeline and clinical-trial intelligence at depth and, like Evaluate, a Norstella company. Pharmaprojects holds over 90,000 drug profiles tracked for over 40 years, and Trialtrove draws on more than 60,000 sources. It is the strongest alternative for teams whose real need is curated R&D and trial data rather than forecasting.

Citeline's Plus products add Ella, an AI chat assistant that helps create and validate search strategies, and Pharmaprojects subscribers get direct access to its therapeutically aligned analysts. It is built for trial planning, site selection and competitive intelligence.

Best for:Trial planning, competitive intelligence, and BD&L teams needing curated pipeline and trial data

Key Features

  • Pharmaprojects: over 90,000 drug profiles, tracked for over 40 years
  • Trialtrove: clinical-trial intelligence from more than 60,000 sources
  • Sitetrove: over 570,000 investigators and more than 199,000 sites in 185 countries
  • Ella AI chat assistant and analyst access

Limitations

  • Pricing is quoted per organization and not published
  • Built for pipeline, trial and site intelligence rather than sales prospecting
Pricing: Citeline does not publish list pricing; contracts are quoted per organization; Pharmaprojects, Trialtrove and Sitetrove are quoted per organization.
4

GlobalData

Visit site

GlobalData's pharmaceutical intelligence platform offers broad coverage in one place: Drugs Intelligence, Trials Intelligence, Therapeutic Analysis and Price Intelligence modules, built on over 290 proprietary datasets that are validated and analyzed by over 2,000 experts and pharma market specialists. Ava is its AI research analyst.

A separate Sales Intelligence product adds buying signals, an AI sales analyst (Sam), account plans and pitch scripts, and pushes account intelligence into Salesforce or HubSpot. GlobalData also delivers through a REST API, Snowflake and an MCP server. It is a capable alternative for market research and strategy teams.

Best for:Market research, forecasting, and strategy teams wanting broad coverage and analyst commentary

Key Features

  • Over 290 proprietary datasets, validated by over 2,000 experts
  • Drugs, Trials and Price Intelligence modules
  • Ava AI research analyst
  • Sales Intelligence with Sam, an AI sales analyst
  • REST API, Snowflake delivery and MCP access

Limitations

  • Platform pricing is not published
  • Built for research and strategy teams
  • Verified emails and dials are not marketed
Pricing: GlobalData does not publish list pricing; contracts are quoted per organization for its platform, though it lists prices for individual store reports and offers trials on request. Vendr reports a median of $68,500 a year (observed range $43,000–$73,875), so treat any single figure as approximate.
5

IQVIA

Visit site

IQVIA describes itself as a leading global provider of advanced analytics, technology solutions and clinical research services, with approximately 93,000 employees and operations in more than 100 countries. Its commercialization business spans data and information management, analytics and consulting, and HCP and patient engagement, including launch strategy, pricing and market access, and brand strategy.

Its real-world data includes patient data from EHRs and claims and longitudinal prescription datasets, and OneKey is its reference data on healthcare professionals and organizations. IQVIA has added agentic AI, including a Field Force Agent that helps field teams plan HCP engagements. It is built for pharma commercial and medical teams engaging healthcare professionals; Salesmotion is built for vendors and service providers selling into sponsors.

Best for:Pharma commercial, medical and real-world-evidence teams that need healthcare data and analytics at global scale

Key Features

  • Real-world data, including patient data from EHRs and claims
  • OneKey reference data on healthcare professionals and organizations
  • Launch strategy, pricing and market access, and brand strategy
  • Field Force Agent and other agentic AI for commercial teams
  • Operations in more than 100 countries

Limitations

  • Pricing is not published; engagements start with a request for proposal
  • Built for analytics and for engaging healthcare professionals rather than sponsor prospecting
Pricing: IQVIA does not publish pricing; its solution pages route to a contact or request-for-proposal form.

Customer Story

How Cytel cut research time by 50% and consolidated 5 research sources into one

50%

less research time

5 → 1

research sources consolidated

30%

faster account planning

“All of the vendors that I've worked with, all of the onboarding that I have had to deal with, I will say, hands down, Salesmotion was the easiest that I have had.”

Lyndsay Thomson

Lyndsay Thomson

Head of Sales Operations, Cytel

Read the full case study

Founder's Take

“Evaluate is the reference for consensus forecasts, and if your job is valuation or market sizing, keep it. Evaluate answers 'what is this market or asset worth?' The question commercial teams bring to us is a different one: 'which sponsors do I sell to, who do I call, and what do I send?' Most teams asking about Evaluate alternatives are really asking one of two things. Do I want a different angle on forecasting and R&D data (Cortellis, GlobalData, IQVIA), or do I need a tool for the selling motion? Those are different categories, and it is worth being clear which one you are shopping in.”
Semir Jahic

Semir Jahic

CEO & Co-Founder, Salesmotion

Summary

Key Takeaways

  1. 1Evaluate, a Norstella company, is the reference source for consensus drug-sales forecasts and valuation: Evaluate Pharma holds 1.5m+ consensus forecasts of 10,000 products dating back to 2003.
  2. 2Evaluate has added AI to that data. Ask Ella is an AI analyst inside Evaluate products that returns sourced, citable answers to plain-English questions, and Norstella Atlas CI is a competitive intelligence agent for pharma and biotech.
  3. 3Evaluate does not publish list pricing; contracts are quoted per organization; its pricing page states pricing is tailored to each organization's data requirements, users and workflows.
  4. 4Cortellis and Citeline are the strongest alternatives for curated R&D and pipeline intelligence; GlobalData adds broad market coverage; IQVIA covers commercial analytics, HCP engagement and real-world evidence.
  5. 5These platforms sell research and data, including to CROs and CDMOs. Salesmotion covers the selling motion itself: signals, verified contacts and drafted outreach.
  6. 6Salesmotion is the alternative for the commercial motion: sponsor discovery, real-time buying signals, verified contacts with phone, and AI outreach, starting at $85/month.
An honest take

Where Salesmotion isn't the right fit

We'd rather you pick the right tool than the wrong one. Salesmotion isn't for everyone — here's when another option on this page is the smarter call.

  • You need a built-in email sequencer or dialer. Salesmotion is account intelligence, not a sending tool — it's built to sit alongside Outreach, Salesloft, or Apollo, not replace them.
  • You're buying purely for raw contact volume. Dedicated data vendors like ZoomInfo and Apollo carry larger raw contact databases.
  • You want a free-forever tier. Salesmotion starts at $85/mo for individuals — there's no free plan.
  • Your motion is pure high-volume SMB outbound. The depth pays off most on considered, higher-ACV deals where understanding the account actually changes the conversation.

Ready to see a better way to sell?

Salesmotion replaces hours of manual research with real-time account intelligence your reps can use today.

Book a DemoSee Product Tour
Head-to-head comparisonEvaluate vs Salesmotion — feature-by-feature
Product

See Salesmotion in Action

Salesmotion life sciences signal feed showing clinical trial, funding, and news signals across sponsor accounts
Real-time sponsor signals across your territory.
Salesmotion sponsor profile showing verified commercial decision-maker contacts with email and phone
Verified commercial contacts with email and phone, plus one-click AI outreach.
FAQ

Frequently Asked Questions

What is the best Evaluate Pharma alternative for BD teams?

It depends on what BD means for your team. For selling services into sponsors, Salesmotion is the best fit, adding sponsor discovery, real-time signals, verified contacts and AI outreach. For forecasting and R&D research, Cortellis, GlobalData and IQVIA are the strongest alternatives to Evaluate Pharma, and sister brand Citeline leads on pipeline and trial data.

How much does Evaluate cost?

Evaluate does not publish list pricing; contracts are quoted per organization; its pricing page states pricing is tailored to each organization's data requirements, users and workflows. The page offers tailored pricing for pharma, financial services, consulting, medtech, CDMO and CRO buyers, and an option to submit an RFP.

Does Evaluate have an AI assistant?

Yes. Ask Ella is the AI analyst that lives inside Evaluate products. You ask a question in plain English and it returns a sourced, citable answer from Evaluate's data. Evaluate also lists Norstella Atlas CI, a competitive intelligence agent for pharma and biotech. Both are research tools; Salesmotion's AI is pointed at a different task, drafting outreach anchored to a sponsor's latest trigger.

Can Salesmotion replace Evaluate?

No, and it is not meant to. Evaluate is the reference for consensus forecasts and valuation. Salesmotion is built for the commercial selling motion: which sponsors to pursue, when, and who to contact. Evaluate informs strategy and finance, Salesmotion drives pipeline, and teams that use both get the best of each.

Is Evaluate the same company as Citeline?

They are sister brands. Evaluate (forecasting) and Citeline (pipeline and trials) are both part of Norstella, the group that also owns MMIT, Panalgo, Skipta and The Dedham Group. Evaluate became part of Norstella in 2020.

Who owns Cortellis now?

Altaris. Clarivate completed the sale of its Life Sciences & Healthcare segment, which includes Cortellis and DRG, to Altaris on 6 October 2026 in a $600 million transaction announced in July 2026. The business now operates as an independent company.

How much do Evaluate alternatives cost?

None of the research and analytics platforms publishes a platform price. The former Clarivate Life Sciences & Healthcare business (Cortellis, DRG), owned by Altaris since October 2026, does not publish list pricing; contracts are quoted per organization; contracts are quoted per organization. Citeline does not publish list pricing; contracts are quoted per organization; Pharmaprojects, Trialtrove and Sitetrove are quoted per organization. GlobalData does not publish list pricing; contracts are quoted per organization for its platform, though it lists prices for individual store reports and offers trials on request. Vendr reports a median of $68,500 a year (observed range $43,000–$73,875), so treat any single figure as approximate. IQVIA does not publish pricing. Salesmotion is the outlier: flexible monthly pricing from $85/month for individuals, with custom team and enterprise pricing and no annual lock-in.

Who are Evaluate's main competitors?

The Evaluate competitors and alternatives compared on this page are Salesmotion, Cortellis (formerly Clarivate), Citeline, GlobalData and IQVIA. Each one is covered above with what it is best for, its published pricing and where it fits.

Need to make the case internally?The Salesmotion business case has the cost, the time math and named customer results on one page, with a short version you can paste into an email or a slide.Read the business case

Related Comparisons

Explore more head-to-head comparisons and alternatives guides.

Evaluate vs SalesmotionCiteline AlternativesClarivate vs SalesmotionGlobalData Alternatives

Give every rep three AI agents to build more pipeline.

A Signal Agent, Research Agent, and Outreach Agent — working 24/7 so your team spends less time researching and more time closing.

Book a demoOr try the interactive demo